Back to search
FDAFDA · Food and drugs·Recall number D-0876-2023

Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807, NDC 65162-212-10.

Published June 21, 2023 · Recall initiated: May 30, 2023

Summary

FDA records drug Class II recall D-0876-2023, published June 21, 2023 and initiated May 30, 2023. Recalling firm: Amneal Pharmaceuticals of New York, LLC; Status: Terminated; Reported quantity: 9,056 bottles; Lot: Lot # HL00721A, Exp. 12/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)

What to do

Voluntary: Firm initiated · Letter

Get an email if EXTENDED PHENYTOIN SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
EXTENDED PHENYTOIN SODIUM
Manufacturer
Amneal Pharmaceuticals of New York, LLC
Distributor
LA, PA and OH.
UPC
0365162212037
Lot
Lot # HL00721A, Exp. 12/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807, NDC 65162-212-10. recalled?

Yes. FDA published recall D-0876-2023 on June 21, 2023. Reported hazard: Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EXTENDED PHENYTOIN SODIUM. UPC: 0365162212037.